Ezdehar, an Egyptian private equity firm, has successfully acquired a minority stake in Yodawy, a healthtech startup based in Egypt. This strategic investment, totaling $10 million, was facilitated through the Ezdehar Mid-Cap Fund II.
The fund enjoys support from prominent entities, including the European Bank for Reconstruction and Development, the European Investment Bank, the British International Investment, the Dutch Entrepreneurial Development Bank, the International Financing Corporation (IFC), Egyptian American Enterprise Fund, and the Belgian Investment Company for Developing Countries, along with a consortium of Egyptian investors.
Ezdehar’s investment in Yodawy is poised to bolster the healthtech startup’s expansion initiatives, with a specific focus on broadening its customer base and enhancing its technology-driven fulfillment capabilities.
Egypt, recognized as the largest pharmaceutical producer in North Africa and the Middle East, boasted a projected market value of $6 billion last year. Private entities such as Yodawy have played a pivotal role in addressing gaps in pharmaceutical delivery left by public institutions.
We have quietly solidified our position as the leading digital pharma powerhouse in Egypt and the preferred partner for payers and providers.
Yodawy’s co-founder and CEO, Karim Khashaba
“Over the past five years, we have concentrated on building a healthcare platform that addresses fundamental challenges in the sector, and we have quietly solidified our position as the leading digital pharma powerhouse in Egypt and the preferred partner for payers and providers,” stated Yodawy’s co-founder and CEO, Karim Khashaba. “Ezdehar’s funding and partnership at this juncture will be instrumental in driving change and supporting our mission to reduce healthcare costs, facilitating patient access to services.”
Yodawy currently serves approximately 35 health insurance and healthcare service companies, holding contracts with over 800 companies, 20 hospitals, and 30 clinics within the market. Additionally, the company has established partnerships with 3,000 pharmacies catering to both chronic and non-chronic conditions across Egypt. Since its inception in 2018, the healthtech startup has successfully facilitated the delivery of more than six million prescriptions.
“Yodawy has identified and capitalized on an untapped opportunity within the prescription and delivery sector, crafting a model that has proven highly effective in meeting the needs of both patients and healthcare providers in the market,” remarked Amir El-Sharqy, General Manager of Ezdehar.
